Portside Wealth Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
38,323
+2,061
+6% +$166K 0.35% 66
2026
Q1
$3.14M Sell
36,262
-1,676
-4% -$161K 0.43% 52
2025
Q4
$3.64M Sell
37,938
-1,084
-3% -$105K 0.49% 47
2025
Q3
$3.72M Buy
39,022
+323
+0.8% +$29.7K 0.51% 47
2025
Q2
$3.37M Sell
38,699
-2,399
-6% -$203K 0.5% 51
2025
Q1
$3.69M Sell
41,098
-16,660
-29% -$1.49M 0.6% 45
2024
Q4
$4.61M Sell
57,758
-947
-2% -$82K 0.76% 29
2024
Q3
$5.29M Buy
58,705
+5,014
+9% +$422K 0.9% 25
2024
Q2
$4.23M Sell
53,691
-1,514
-3% -$124K 0.81% 26
2024
Q1
$4.81M Buy
55,205
+515
+0.9% +$44K 0.89% 24
2023
Q4
$4.51M Sell
54,690
-2,626
-5% -$200K 0.84% 28
2023
Q3
$4.49M Buy
57,316
+2,643
+5% +$221K 0.85% 32
2023
Q2
$4.82M Buy
+54,673
New +$4.71M 0.89% 27

Other funds holding MDT

Portside Wealth Group's MDT Position: Q2 2026 in Review

Portside Wealth Group increased its Medtronic (MDT) stake by 5.7% in Q2 2026, buying an estimated $166K and bringing the position to 38,323 shares worth $3M. The position accounts for 0.35% of the portfolio, ranked #66.

Portside Wealth Group first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.29M in Q3 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Portside Wealth Group held 38,323 shares of Medtronic worth $3M as of Q2 2026.
  • Portside Wealth Group bought 2,061 Medtronic shares in Q2 2026, an estimated $166K.
  • Medtronic made up 0.35% of Portside Wealth Group's portfolio in Q2 2026, its #66 holding.
  • Portside Wealth Group first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
  • Portside Wealth Group's Medtronic position peaked at $5.29M in Q3 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.